MedTrace Logo

Oral Fluid Screening Devices

NCT00571207 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2011-09-02

No results posted yet for this study

Summary

This research includes the evaluation of a checklist and on-site screening devices to pre-select drivers suspected of being drug-impaired. The reliability of a limited number of promising on-site screening devices will be investigated. The devices tested will have to be promising regarding both reliability and practicality. In addition to the scientific evaluation of the checklist and the oral fluid screening devices, the time consumption of the selection procedure as a whole (checklist + oral fluid screening) will be evaluated.

Outcome of the study will be recommendations for the roadside selection procedure of drivers suspected of drug-related impairment. The recommendations will concentrate on the reliability of the selection procedure.

The study is part of an EU project DRUID. Two other countries in Europe take part to this study along with Finland.

Conditions

  • Drug-impaired Driving

Interventions

DEVICE

On-site oral fluid screening devices

Comparison of screening device results to oral and/or blood sample results

BEHAVIORAL

Checklist: drug recognition expert

Correlation of drug recognition expert observations to findings for drugs in non-suspected/suspected cases

Sponsors & Collaborators

  • Hospital District of Helsinki and Uusimaa

    collaborator OTHER

  • European Commission

    collaborator OTHER

  • Finnish Institute for Health and Welfare

    lead OTHER_GOV

Principal Investigators

  • Pirjo Lillsunde, Dr · National Public Health Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-30
Completion
2010-10-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00571207 on ClinicalTrials.gov